Official Title
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Brief Title
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Protocol ID
NCT01258231
Lead Sponsor
Brigham and Women's Hospital
Brief Summary
This study aims to identify genetic causes of adverse events after cardiac surgery, such
as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.
Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart
Institute are eligible to participate.
Detailed Description
This study aims to identify genetic causes of adverse events after cardiac surgery, such
as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In
addition, we also examine blood and urine biomarkers (proteins).
Enrollment Count
4,000 participants
Eligibility Criteria
Inclusion Criteria:
- Undergoing heart surgery
- Willing to provide consent
Exclusion Criteria:
- Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Filters
Heart; Dysfunction Postoperative, Cardiac Surgery
Genetic Predisposition to Disease
Atrial Fibrillation
Myocardial Infarction
Heart Failure
RECRUITING
ADULT
OLDER_ADULT